SUZHOU, China, Dec. 29, 2025 /PRNewswire/ — Alphamab Oncology (Stock Code: 9966.HK) announced that the IND application for a Phase II clinical study of JSKN033 (a proprietary high-concentration subcutaneous co-formulation consisting of HER2 bispecific antibody-drug conjugate (ADC) and PD-L1 immune checkpoint inhibitor) in combination with platinum-based chemotherapy with or without bevacizumab as first-line treatment of advanced cervical cancer (Study Number: JSKN033-202), has been officially accepted by the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA).

Cervical cancer is the most common gynecological malignancy and the fourth leading cause of cancer-related deaths among women. Patients with early-stage disease often experience recurrence or metastasis within two years after treatment, while those with advanced disease have a poor prognosis, with a five-year survival rate of less than 20%. Currently, platinum-based (cisplatin or carboplatin) chemotherapy combined with bevacizumab represents the guideline-recommended first-line standard of care. Although immune checkpoint inhibitors have also achieved breakthrough progress, tumor heterogeneity in cervical cancer still leads to suboptimal responses in some patients, highlighting a clear unmet clinical need.

In recent years, multiple clinical studies have confirmed the synergistic potential of combining ADCs with immunotherapy and anti-angiogenic agents. As a first-in-class co-formulation of ADC and immune checkpoint inhibitor, JSKN033 leverages a dual mechanism of action, combining targeted tumor killing with immune activation. In early-stage clinical studies, JSKN033 monotherapy has demonstrated promising efficacy and a manageable safety profile in patients with cervical cancer who have failed standard therapies.

JSKN033-202 is an open-label, multicenter phase II clinical trial designed to evaluate the safety, efficiency and pharmacokinetics (PK)/pharmacodynamics (PD) of JSKN033 in combination with platinum-based chemotherapy, with or without bevacizumab, as first-line treatment for patients with advanced cervical cancer. All patients will receive treatment with JSKN033 plus either cisplatin or carboplatin, with or without bevacizumab, with the choice of platinum agent and the use of bevacizumab determined by the investigator based on individual patient circumstances. The initiation of this study is expected to provide an innovative and convenient treatment option for patients with advanced cervical cancer.

About JSKN033

JSKN033 is the global first high-concentration subcutaneous formulation, combining the ADC (JSKN003) with PD-L1(Envafolimab), which is independently developed by the Company. JSKN003 is developed by site-specific conjugation to the Fc glycans of Anbenitamab (KN026), resulting in a homogeneous and stable ADC with a drug-to-antibody ratio (DAR) of 4. JSKN003 binds to two HER2 epitopes on tumor cells and release topoisomerase I inhibitors through cellular endocytosis, exerting anti-tumor effects. Envafolimab is a Fc fusion protein consisting of humanized anti-PD-L1 single domain antibody and human IgG1 Fc fragment, which has been approved by Chinese authorities as the global-first subcutaneous injection PD-(L)1 inhibitor in November 2021.

JSKN033 combines the benefits of immunotherapy and ADCs while enhancing safety and convenience through subcutaneous administration.

Currently, Phase I/II clinical trials of JSKN033 for the treatment of solid tumors is being conducted in China and Australia. The IND application for the Phase II clinical study of JSKN033 in combination with chemotherapy as first-line treatment for advanced cervical cancer has been accepted by the CDE.

About Alphamab Oncology

Alphamab Oncology (Stock Code: 9966.HK) is an innovative biopharmaceutical company focused on oncology. Leveraging proprietary platforms-including single-domain antibodies, bispecific antibodies, glycan-specific conjugation, linker-payloads, dual-payload ADCs, and high-concentration subcutaneous formulations, the Company has built a differentiated and globally competitive pipeline, covering cutting-edge candidates in ADCs, bispecific antibodies, and single-domain antibodies.

One product has received market approval: Envafolimab (KN035, brand name: 恩维达^®), the world’s first subcutaneously injected PD-(L)1 inhibitor, offering greater convenience and accessibility in cancer treatment. The NMPA has accepted the new drug application for KN026 (Anbenitamab Injection), a HER2 bispecific antibody, for second-line or later HER2-positive gastric cancer. Four bispecific ADC candidates have entered clinical stages, and next-generation ADC pipelines—such as dual-payload ADCs—are advancing rapidly. The Company has established strategic partnerships with organizations including CSPC, ArriVent, and Glenmark, covering both product development and technology platforms.

Our overarching mission is to make cancer manageable and curable by addressing unmet clinical needs in oncology. Alphamab Oncology is continuously dedicated to the development of effective, safe, and globally competitive anti-tumor drugs, delivering China-innovated cancer therapies to benefit patients worldwide.

• XPENG-PKU Research Breakthrough: XPENG, in collaboration with Peking University, has developed FastDriveVLA—a novel visual token pruning framework that enables autonomous driving AI to “drive like a human” by focusing only on essential information, achieving a 7.5x reduction in computational load.
• Top-Tier AI Recognition: The research has been accepted by AAAI 2026, one of the world’s premier AI conferences, which had a highly selective acceptance rate of just 17.6% this year.
• Accelerating L4 Autonomy: This achievement underscores XPENG’s full-stack capabilities in AI-driven mobility and advances the industry toward efficient, scalable deployment of next-generation autonomous driving systems.

GUANGZHOU, China, Dec. 28, 2025 /PRNewswire/ — XPENG, in collaboration with Peking University, has had its paper “FastDriveVLA: Efficient End-to-End Driving via Plug-and-Play Reconstruction-based Token Pruning” accepted by AAAI 2026, one of the world’s top conferences in artificial intelligence. AAAI 2026 received 23,680 submissions, with only 4,167 papers accepted, an acceptance rate of just 17.6%.

The paper introduces FastDriveVLA, an efficient visual token pruning framework specifically designed for end-to-end autonomous driving Vision-Language-Action (VLA) models. This work offers a new approach to visual token pruning by enabling AI to “drive like a human”, focusing only on essential visual information while filtering out irrelevant data.

As AI large models evolve rapidly, VLA models are being widely adopted in end-to-end autonomous driving systems due to their strong capabilities in complex scene understanding and action reasoning. These models encode images into large numbers of visual tokens, which serve as the foundation for the model to “see” the world and make driving decisions. However, processing large numbers of tokens increases computational load onboard the vehicle, impacting inference speed and real-time performance.

While visual token pruning has been recognized as a viable method to accelerate VLA inference, existing approaches, whether based on text-visual attention or token similarity, have shown limitations in driving scenarios. To address this, XPENG and PKU developed FastDriveVLA, a novel reconstruction-based token pruning framework inspired by how human drivers focus on relevant foreground information while ignoring non-critical background areas.

The method introduces an adversarial foreground-background reconstruction strategy that enhances the model’s ability to identify and retain valuable tokens. On the nuScenes autonomous driving benchmark, FastDriveVLA achieved state-of-the-art performance across various pruning ratios. When the number of visual tokens was reduced from 3,249 to 812, the framework achieved a nearly 7.5x reduction in computational load while maintaining high planning accuracy.

This is the second time this year that XPENG has been recognized at top-tier global AI conference. In June, XPENG was the only Chinese automaker invited to speak at CVPR WAD, where it shared advances in autonomous driving foundation models. At its AI Day in November, XPENG unveiled VLA 2.0 architecture, which removes the “language translation” step and enables direct Visual-to-Action generation, a breakthrough that redefines the conventional V-L-A pipeline.

These accomplishments reflect XPENG’s full-stack in-house capabilities, from model architecture design and training to distillation and vehicle deployment. Looking ahead, XPENG remains committed to achieving L4 level autonomous driving to accelerate the integration of physical AI systems into vehicles, with the goal of delivering safe, efficient, and comfortable intelligent driving experiences to users around the world.

About XPENG
XPENG is committed to leading the transformation of future mobility through technological exploration, positioning itself as “Explorer of Future Mobility”. Headquartered in Guangzhou, China, the company operates R&D centers in Beijing, Shanghai, Shenzhen, Zhaoqing, and Yangzhou, and has established intelligent manufacturing bases in Zhaoqing and Guangzhou.

XPENG pursues a global strategy for research, development, and sales, with an R&D center in the United States and subsidiaries across multiple European countries. The company adheres to full-stack in-house development of intelligent driver-assistance software and the development of core hardware, delivering an exceptional intelligent driving and riding experience for users.

On August 27, 2020, XPENG officially listed on the New York Stock Exchange (NYSE: XPEV), raising funds in an IPO that set a record at the time for the global new energy vehicle industry. On July 7, 2021, the company listed on the Hong Kong Stock Exchange (HKEX: 9868), becoming the first Chinese new-energy automaker to achieve dual primary listings in both Hong Kong and New York.

For more information, please visit https://www.xpeng.com/.

Contacts:
For Media Enquiries: Alison Liang, XPENG PR Department
Email: liangrq3@xiaopeng.com 

SHANGRAO, China, Dec. 29, 2025 /PRNewswire/ — JinkoSolar Holding Co., Ltd. (“JinkoSolar” or the “Company”) (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that all shareholders resolutions proposed at the Company’s 2025 annual general meeting held today were duly passed. Specifically, the Company’s shareholders passed the following ordinary resolutions approving:

1. The re-election of Mr. Haiyun Cao as a director of the Company;
2. The re-election of Mr. Wing Keong Siew as an independent director of the Company;
3. The ratification of the appointment of PricewaterhouseCoopers Zhong Tian LLP as auditors of the Company for the fiscal year of 2025;
4. The authorization of the directors of the Company to determine the remuneration of the auditors of the Company; and
5. The authorization of each of the directors of the Company be authorized to take any and all action that might be necessary to effect the foregoing resolutions 1 to 4 as such director, in his or her absolute discretion, thinks fit.

 About JinkoSolar Holding Co., Ltd.

JinkoSolar (NYSE: JKS) is one of the largest and most innovative solar module manufacturers in the world. JinkoSolar distributes its solar products and sells its solutions and services to a diversified international utility, commercial and residential customer base in China, the United States, Japan, Germany, the United Kingdom, Chile, South Africa, India, Mexico, Brazil, the United Arab Emirates, Italy, Spain, France, Belgium, Netherlands, Poland, Austria, Switzerland, Greece and other countries and regions.

JinkoSolar had over 10 productions facilities globally, over 20 overseas subsidiaries in Japan, South Korea, Vietnam, India, Turkey, Germany, Italy, Switzerland, the United States, Mexico, and other countries, and a global sales network with sales teams in China, the United States, Canada, Brazil, Chile, Mexico, Italy, Germany, Turkey, Spain, Japan, the United Arab Emirates, Netherlands, Vietnam and India, as of September 30, 2025.

To find out more, please see: www.jinkosolar.com

For investor and media inquiries, please contact:

In China:

Ms. Stella Wang
JinkoSolar Holding Co., Ltd.
Tel: +86 21-5180-8777 ext.7806
Email: ir@jinkosolar.com 

Mr. Christian Arnell
Christensen
Tel: +852 2117 0861
Email: christian.arnell@christensencomms.com

In the U.S.:

Ms. Linda Bergkamp
Christensen, Scottsdale, Arizona
Tel: +1-480-614-3004
Email: linda.bergkamp@christensencomms.com

BEIJING, Dec. 29, 2025 /PRNewswire/ — CGTN’s “China’s Coldest City, Hottest Party” is a look at the rise in popularity of Dongbei, or China’s Northeast, as a top winter destination. It is also the story of a region where snow and ice once felt like barriers to progress, but once harvested quickly proved to be catalysts for incredible progress and prosperity.

Having previously been a major industrial powerhouse inside China, the region was now being left behind by the staggering rise of warmer regions and cities to the south. For over two decades, the revitalization of Dongbei has been a key national strategy in China. Brother Left and Right, as he is affectionately called by his fans, has witnessed the revitalization of Dongbei thanks to visionary government policies and the spirit of its people.

Watching him jump up and down on the stage, firing up crowds at Harbin’s massive Ice and Snow World, it becomes clear why he is China’s hottest wintertime influencer. Experiencing what might be the world’s greatest winter party surrounded by larger-than-life ice sculptures certainly takes your breath away. It is no wonder why Dongbei is so popular in China these days, and why its people are so optimistic about the future.

Dongbei’s revitalization is a success story, of a land reshaped by policy and a can-do attitude. Besides ice sculptures and winter parties, new industries and factories, as well as ski resorts, are also reshaping Dongbei. This boom in popularity and opportunity is solid proof that China’s ice and snow economy is as valuable as a mountain of gold and silver. And there is no better time than now to go take a look for yourself.

SINGAPORE, Dec. 29, 2025 /PRNewswire/ — HashMicro, a leading enterprise software provider in Southeast Asia, has released new strategic insights on how enterprises are redefining inventory management in 2026. Drawing from its experience supporting more than 2,000 enterprise organizations, HashMicro highlights the critical factors businesses must evaluate when selecting inventory management software in an increasingly complex and competitive environment.

According to HashMicro, inventory management has evolved from a back-office function into a core business capability that directly influences profitability, customer experience, and operational resilience. As enterprises expand across multiple locations, sales channels, and supply networks, the need for intelligent, integrated, and scalable inventory management systems has never been more urgent.

Why Inventory Strategy Is a Board-Level Priority in 2026

HashMicro’s enterprise research indicates that organizations without modern inventory management software continue to face persistent challenges, including frequent stockouts, costly overstocking, limited stock visibility, and inefficient warehouse operations. These issues not only increase operational costs but also weaken service levels and long-term competitiveness.

Modern inventory management systems, according to HashMicro, are now expected to deliver real-time visibility, advanced automation, and accurate forecasting to enable enterprises to maintain optimal stock levels, streamline fulfillment operations, and strengthen supply chain performance.

Seven Key Factors Enterprises Must Evaluate

Based on HashMicro’s analysis, enterprises evaluating inventory management software in 2026 consistently prioritize the following criteria:

1. Stock Visibility and Movement Tracking

Enterprises require inventory systems that record every item transfer, adjustment, and transaction in real time across all locations. Advanced barcode scanning, serial number management, and lot tracking ensure full traceability from receiving and storage through dispatch and returns.

2. Intelligent Replenishment, Optimization, and Forecasting

Leading organizations seek automated replenishment that continuously monitors stock thresholds and triggers purchasing or production activities when quantities reach predefined limits. Stock optimization engines and forecasting systems analyze historical demand and emerging trends to prevent both overstocking and shortages.

3. Automation and Workflow Efficiency

Enterprises prioritize platforms that streamline recurring processes such as order processing, returns management, quality inspections, document generation, and reporting. AI-powered tools are increasingly used to provide alerts, automate internal transfers, and surface actionable insights for faster decision-making.

4. Multi-Channel and Multi-Location Operations

Modern enterprises require unified inventory systems that synchronize stock data in real time across warehouses, physical stores, and e-commerce channels. Support for multi-warehouse control and omnichannel fulfillment ensures consistent inventory information at every customer touchpoint.

5. Integration with Finance, Sales, and Supply Chain

Inventory platforms are evaluated on their ability to integrate seamlessly with accounting, ERP, procurement, sales, logistics, invoicing, and analytics systems. This integration reduces manual data entry, minimizes errors, and provides leadership with accurate cross-functional visibility.

6. Industry Fit and Deployment Flexibility

Enterprises increasingly prefer solutions that offer industry-specific functionality for sectors such as manufacturing, retail, food and beverage, and e-commerce. Cloud-based deployment, scalable licensing, and configurable features allow organizations to tailor system complexity while supporting future growth.

7. Usability, Scalability, and Enterprise Support

Ease of use, intuitive interfaces, and the ability to support expanding user bases are critical for large, distributed teams. After-sales support quality, implementation timelines, and long-term system maintainability also play a decisive role in enterprise software selection.

From Evaluation Criteria to Enterprise Execution

In practice, HashMicro’s enterprise inventory implementations already encompass the complete range of capabilities described above, while continuing to evolve with advanced automation, AI-driven intelligence, expanded reporting, and deeper system integration to support future business demands.

Through its ongoing work with enterprise organizations, HashMicro has observed that modern inventory management platforms must deliver not only the full scope of core capabilities, including real-time stock visibility, automated replenishment, intelligent optimization, forecasting, multi-location synchronization, and cross-functional integration, but also continuous innovation in automation, analytics, and system architecture to remain competitive in 2026 and beyond.

This approach allows enterprises to move beyond basic stock control and build inventory operations that are resilient, adaptive, and strategically aligned with long-term growth.

HashMicro’s Perspective on the Future of Inventory Management

HashMicro reports that leading enterprises are increasingly adopting inventory platforms that combine real-time stock monitoring, automated reordering, low-stock alerts, expiry tracking, internal transfer automation, AI-driven decision support, and advanced reporting dashboards that transform operational data into actionable business intelligence.

By aligning inventory operations with finance, sales, procurement, and supply chain functions, enterprises are transforming inventory management into a strategic growth driver rather than a cost center.

Building Future-Ready Inventory Operations

As supply chains grow more dynamic and customer expectations continue to rise, HashMicro believes that enterprises must invest in inventory management systems that deliver intelligence, automation, scalability, and deep operational integration at enterprise scale.

Organizations that adopt modern inventory platforms, according to HashMicro, will be best positioned to achieve operational stability, stronger financial performance, and sustainable long-term growth in 2026 and beyond.